GlassScriptPhysician profile
Akbarshakh Akhmerov
NPI 1215464276
$1,985.65
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2021: $93.00 · 2022: $638 · 2023: $916 · 2024: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $540 · Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $539.88 |
| Food and Beverage | $533.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $916.08 | 2023 | Inspiris Resilia Aortic Valve |
| Intuitive Surgical, INC. | $355.80 | 2022 | |
| Atricure, INC. | $190.91 | 2022 | |
| La Jolla Pharmaceutical Company | $181.46 | 2019 | |
| Xvivo Perfusion INC. | $137.17 | 2024 | Xvivo Perfusion System (Xps) |
| Medical Device Business Services, INC. | $136.00 | 2021-2022 | |
| Baxter Healthcare | $48.44 | 2022 | |
| W. L. Gore & Associates, INC. | $19.79 | 2024 | Gore Tag Thoracic Branch Endoprosthesis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akbarshakh Akhmerov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.